Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Amifostine may be effective in relieving numbness, tingling, and other symptoms of
peripheral neuropathy. It is not yet known whether amifostine is effective in treating
peripheral neuropathy in patients who have received chemotherapy for cancer.
PURPOSE: This randomized phase III trial is studying amifostine to see how well it works
compared to observation in relieving numbness, tingling, and other symptoms of peripheral
neuropathy in patients who have received platinum-based chemotherapy (such as cisplatin or
carboplatin) for cancer.